Related Experiment Video
Updated: Aug 14, 2026

Characterization and Functional Prediction of Bacteria in Ovarian Tissues
Published on: October 23, 2021
Use, understanding, and perceptions of gut microbiome research and practices in oncology
Courtney B Cross1,2, Maya R Davies3,4, Elin Irestorm5,6
1School of Pharmacy and Biomedical Sciences, College of Health, Adelaide University, Adelaide, Australia. courtney.cross@adelaide.edu.au.
Purpose:
The gut microbiome has gained increasing recognition as an important factor influencing cancer treatment efficacy and toxicity. However, translation of this knowledge to deliver clinical benefit has been hampered by inconsistent approaches to both biospecimen sampling and investigation of microbial-based interventions, potentially reflecting inherent biases and/or barriers across research environments. Accordingly, we aimed to characterize the current practices and perceptions surrounding the gut microbiome among members of the Multinational Association of Supportive Care in Cancer (MASCC).
Methods:
A mixed-methods survey, probing current research and/or clinical use, plans, and perceptions of the gut microbiome in oncology, was developed in 2022 and distributed MASCC-wide via REDCap. Quantitative data were summarized using descriptive analyses, and qualitative responses were independently dual-coded using inductive thematic analysis.
Results:
Out of 117 respondents, the majority (83%) held the belief that the gut microbiome plays an important role in disease states such as cancer. 44.4% of survey respondents reported ongoing research or clinical practice regarding the gut microbiome at their center, with 70.5% also expressing an interest in developing such a program. Qualitative analysis revealed 6 main themes: (1) state of the evidence, (2) significance of the microbiome, (3) uncertainty, (4) aspirations, (5) preferences, and (6) critique.
Conclusions:
This survey identifies general concordance on the importance of the gut microbiome in cancer. Despite interest in this field, there is a clear need for resource support (i.e., funding and infrastructure) and increased expertise to support high-quality trials generating the evidence required for implementation of microbial-based sampling or therapeutics in clinical practice.
Insights
The gut microbiome is recognized for its role in cancer treatment. However, more resources and expertise are needed to translate this understanding into clinical practice, despite widespread interest among supportive care professionals.
Area of Science:
- Oncology
- Microbiome Research
- Cancer Therapeutics
Background:
- The gut microbiome's influence on cancer treatment efficacy and toxicity is increasingly acknowledged.
- Translating microbiome research into clinical benefits is challenging due to inconsistent methods and potential research biases.
- Understanding current practices and perceptions is crucial for advancing microbiome-based cancer care.
Purpose of the Study:
- To characterize the current practices and perceptions of the gut microbiome within the Multinational Association of Supportive Care in Cancer (MASCC).
- To identify barriers and facilitators for integrating gut microbiome research and clinical applications in oncology.
Main Methods:
- A mixed-methods survey was distributed to MASCC members in 2022.
- The survey collected data on current research, clinical use, future plans, and perceptions of the gut microbiome in cancer care.
- Quantitative data were analyzed using descriptive statistics, and qualitative responses underwent inductive thematic analysis.
Main Results:
- A majority of respondents (83%) believe the gut microbiome is important in cancer.
- 44.4% reported ongoing gut microbiome research or clinical practice, with 70.5% interested in developing such programs.
- Qualitative analysis identified key themes including the state of evidence, perceived significance, uncertainty, aspirations, preferences, and critiques regarding microbiome research.
Conclusions:
- There is broad agreement on the significance of the gut microbiome in cancer care.
- Significant interest exists in leveraging the gut microbiome, but resource support (funding, infrastructure) and expertise are lacking.
- High-quality trials are needed to generate evidence for implementing microbiome-based sampling or therapeutics in clinical practice.
More Related Videos
Related Concept Videos
What is Monogastric Digestion?
Introduction to the Human Microbiota
Microbiota Modulation by Antibiotics
The Oral Microbiota
Dysbiosis of the Gut Microbiota

